OptiNose, Inc. (NASDAQ:OPTN) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET
Company Participants
Jonathan Neely - IR
Peter Miller - CEO
Keith Goldan - CFO
Vic Clavelli - Chief Commercial Officer
Ramy Mahmoud - President and COO
Conference Call Participants
Stacey Ku - Cowen
Dave Amsellem - Piper Sandler
Gary Nachman - BMO Capital Markets
Brandon Folkes - Cantor Fitzgerald
Operator
Good day, and thank you for standing by. Welcome to the OptiNose First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions].
I would now like to hand the conference over to your host, Jonathan Neely, Investor Relations. Please go ahead.
Jonathan Neely
Good morning, and thank you for joining us today as we review OptiNose's first quarter 2021 performance and our plans for the remainder of the year. I'm joined today by our CEO, Peter Miller; President and Chief Operating Officer, Ramy Mahmoud; our Chief Commercial Officer, Vic Clavelli; and our CFO, Keith Goldan.
The slides that we’ll be presented on this call, can be viewed on our website, optinose.com, in the Investors section.
Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements. All statements that are not historical facts are hereby identified as forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated by such statements.
Additional information regarding these factors and forward-looking statements is discussed under the cautionary note on forward-looking statements section of the earnings release that we issued today as well as under the Risk Factors section and elsewhere in OptiNose's most recent Form 10-K and Form 10-Q that is filed with the SEC and available at their website, sec.gov and on our website at optinose.com.
You are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements during this conference call speak only as of the original date of this call or any earlier date indicated in such statement, and we undertake no obligation to update or revise any of these statements. We will now make prepared remarks, and then we will move to a question-and-answer session.
With that, I will now turn the call over to Peter Miller. Peter?